Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FTC raises anticompetitive concerns about FDA naming proposal for biosimilars
FTC raises anticompetitive concerns about FDA naming proposal for biosimilars
FTC raises anticompetitive concerns about FDA naming proposal for biosimilars
Submitted by
admin
on October 29, 2015 - 6:16pm
Source:
Pharmalot
News Tags:
FTC
FDA
biosimilars
drug names
Headline:
FTC raises anticompetitive concerns about FDA naming proposal for biosimilars
Do Not Allow Advertisers to Use My Personal information
